Live from the NIH registry
Studies recruiting near Waco right now
Top 25 of 54 recruiting studies, sorted by proximity — each links to its official registry page
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Texas Oncology - Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Velocity Clinical Research — Waco, Texas (2.6 mi)
· Sponsor: Janssen Research & Development, LLC
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
ActiveTherapy Alliance — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: Akero Therapeutics, Inc
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
Post-operative Pain Management
N/A
Interventional 148 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: University of California, Los Angeles
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Velocity Clinical Research Waco — Waco, Texas (2.6 mi)
· Sponsor: Housey Healthcare ULC
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Waco, Texas (2.6 mi)
· Sponsor: DalCor Pharmaceuticals
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Peripheral Arterial Disease
Phase 3
Interventional 1,205 participants sought
NextStage Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Primary Biliary Cholangitis, PBC
Phase 2
Interventional 260 participants sought
Impact Research — Waco, Texas (2.6 mi)
· Sponsor: Mirum Pharmaceuticals, Inc.
BOOM-IBD2 Pivotal Clinical Trial
Ulcerative Colitis, Inflammatory Bowel Diseases
N/A
Interventional 137 participants sought
Digestive Research of Central Texas (Objective Health) — Waco, Texas (2.6 mi)
· Sponsor: Boomerang Medical
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Gout
Phase 2
Interventional 90 participants sought
Velocity Clinical Research (Impact Research Institute) — Waco, Texas (2.6 mi)
· Sponsor: Crystalys Therapeutics
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2, Phase 3
Interventional 650 participants sought
Site #0152 — Waco, Texas (2.6 mi)
· Sponsor: Bicara Therapeutics
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 3
Interventional 500 participants sought
Texas Oncology-Central South — Waco, Texas (2.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Texas Oncology - Central South (Horizon Cir) — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ulcerative Colitis, Crohn's Disease
Phase 4
Interventional 200 participants sought
Digestive Research of Central Texas, LLC — Waco, Texas (2.6 mi)
· Sponsor: Takeda
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Waco, Texas (2.6 mi)
· Sponsor: AstraZeneca
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Digestive Research of Central Texas, LLC — Waco, Texas (2.6 mi)
· Sponsor: Chugai Pharmaceutical
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Texas Oncology - Waco — Waco, Texas (2.6 mi)
· Sponsor: Agendia
Reliability and Validity of the PReFS
Neurologic Disorders, Spinal Cord Injury
N/A
Observational 15 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Nextstage Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 8618 — Waco, Texas (2.6 mi)
· Sponsor: Galderma R&D
Paper-Based and Smartphone-Based Memory Supports
Alzheimer Disease, Dementia, Mild
N/A
Interventional 200 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
National Sponsorship Program for Transitioning Service Members
Reintegration Difficulties, Health
N/A
Interventional 630 participants sought
Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX — Waco, Texas (2.6 mi)
· Sponsor: VA Office of Research and Development